These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 34523960

  • 1. APOBEC3B Potently Restricts HIV-2 but Not HIV-1 in a Vif-Dependent Manner.
    Bandarra S, Miyagi E, Ribeiro AC, Gonçalves J, Strebel K, Barahona I.
    J Virol; 2021 Nov 09; 95(23):e0117021. PubMed ID: 34523960
    [Abstract] [Full Text] [Related]

  • 2. HIV-2 Vif and foamy virus Bet antagonize APOBEC3B by different mechanisms.
    Zhang Z, Perković M, Gu Q, Balakrishnan K, Sangwiman A, Häussinger D, Lindemann D, Münk C.
    Virology; 2021 Feb 09; 554():17-27. PubMed ID: 33333348
    [Abstract] [Full Text] [Related]

  • 3. Vif Proteins from Diverse Human Immunodeficiency Virus/Simian Immunodeficiency Virus Lineages Have Distinct Binding Sites in A3C.
    Zhang Z, Gu Q, Jaguva Vasudevan AA, Jeyaraj M, Schmidt S, Zielonka J, Perković M, Heckel JO, Cichutek K, Häussinger D, Smits SHJ, Münk C.
    J Virol; 2016 Nov 15; 90(22):10193-10208. PubMed ID: 27581978
    [Abstract] [Full Text] [Related]

  • 4. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
    Wang J, Shaban NM, Land AM, Brown WL, Harris RS.
    J Virol; 2018 Jun 15; 92(12):. PubMed ID: 29618650
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. APOBEC3 degradation is the primary function of HIV-1 Vif determining virion infectivity in the myeloid cell line THP-1.
    Ikeda T, Shimizu R, Nasser H, Carpenter MA, Cheng AZ, Brown WL, Sauter D, Harris RS.
    mBio; 2023 Aug 31; 14(4):e0078223. PubMed ID: 37555667
    [Abstract] [Full Text] [Related]

  • 8. APOBEC3C Tandem Domain Proteins Create Super Restriction Factors against HIV-1.
    McDonnell MM, Crawford KHD, Dingens AS, Bloom JD, Emerman M.
    mBio; 2020 Apr 28; 11(2):. PubMed ID: 32345636
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
    Land AM, Wang J, Law EK, Aberle R, Kirmaier A, Krupp A, Johnson WE, Harris RS.
    Oncotarget; 2015 Nov 24; 6(37):39969-79. PubMed ID: 26544511
    [Abstract] [Full Text] [Related]

  • 11. Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases.
    Zhang W, Huang M, Wang T, Tan L, Tian C, Yu X, Kong W, Yu XF.
    Cell Microbiol; 2008 Aug 24; 10(8):1662-75. PubMed ID: 18419775
    [Abstract] [Full Text] [Related]

  • 12. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
    He Z, Zhang W, Chen G, Xu R, Yu XF.
    J Mol Biol; 2008 Sep 12; 381(4):1000-11. PubMed ID: 18619467
    [Abstract] [Full Text] [Related]

  • 13. Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein.
    Pery E, Sheehy A, Nebane NM, Brazier AJ, Misra V, Rajendran KS, Buhrlage SJ, Mankowski MK, Rasmussen L, White EL, Ptak RG, Gabuzda D.
    J Biol Chem; 2015 Apr 17; 290(16):10504-17. PubMed ID: 25724652
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
    Ara A, Love RP, Follack TB, Ahmed KA, Adolph MB, Chelico L.
    J Virol; 2017 Feb 01; 91(3):. PubMed ID: 27881650
    [Abstract] [Full Text] [Related]

  • 15. Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif.
    Pery E, Rajendran KS, Brazier AJ, Gabuzda D.
    J Virol; 2009 Mar 01; 83(5):2374-81. PubMed ID: 19109396
    [Abstract] [Full Text] [Related]

  • 16. A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits.
    Cheng AZ, Moraes SN, Attarian C, Yockteng-Melgar J, Jarvis MC, Biolatti M, Galitska G, Dell'Oste V, Frappier L, Bierle CJ, Rice SA, Harris RS.
    J Virol; 2019 Dec 01; 93(23):. PubMed ID: 31534038
    [Abstract] [Full Text] [Related]

  • 17. HIV-1 Vif interaction with APOBEC3 deaminases and its characterization by a new sensitive assay.
    Cadima-Couto I, Saraiva N, Santos AC, Goncalves J.
    J Neuroimmune Pharmacol; 2011 Jun 01; 6(2):296-307. PubMed ID: 21279453
    [Abstract] [Full Text] [Related]

  • 18. Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.
    Goila-Gaur R, Khan MA, Miyagi E, Kao S, Strebel K.
    Retrovirology; 2007 Aug 29; 4():61. PubMed ID: 17727729
    [Abstract] [Full Text] [Related]

  • 19. The activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3H.
    Binka M, Ooms M, Steward M, Simon V.
    J Virol; 2012 Jan 29; 86(1):49-59. PubMed ID: 22013041
    [Abstract] [Full Text] [Related]

  • 20. APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication.
    Yu Q, Chen D, König R, Mariani R, Unutmaz D, Landau NR.
    J Biol Chem; 2004 Dec 17; 279(51):53379-86. PubMed ID: 15466872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.